- Home
- SLS vs PDEX Comparison
SLS vs PDEX Comparison
Compare SLS & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLS
- PDEX
- Stock Information
- Founded
- SLS 2012
- PDEX 1978
- Country
- SLS United States
- PDEX United States
- Employees
- SLS N/A
- PDEX N/A
- Industry
- SLS Biotechnology: Pharmaceutical Preparations
- PDEX Medical/Dental Instruments
- Sector
- SLS Health Care
- PDEX Health Care
- Exchange
- SLS Nasdaq
- PDEX Nasdaq
- Market Cap
- SLS 185.3M
- PDEX 152.3M
- IPO Year
- SLS N/A
- PDEX N/A
- Fundamental
- Price
- SLS $1.69
- PDEX $32.69
- Analyst Decision
- SLS Strong Buy
- PDEX Strong Buy
- Analyst Count
- SLS 1
- PDEX 1
- Target Price
- SLS $7.00
- PDEX $56.00
- AVG Volume (30 Days)
- SLS 2.0M
- PDEX 35.9K
- Earning Date
- SLS 11-12-2025
- PDEX 10-30-2025
- Dividend Yield
- SLS N/A
- PDEX N/A
- EPS Growth
- SLS N/A
- PDEX 345.00
- EPS
- SLS N/A
- PDEX 2.67
- Revenue
- SLS N/A
- PDEX $66,593,000.00
- Revenue This Year
- SLS N/A
- PDEX $7.22
- Revenue Next Year
- SLS N/A
- PDEX N/A
- P/E Ratio
- SLS N/A
- PDEX $12.45
- Revenue Growth
- SLS N/A
- PDEX 23.68
- 52 Week Low
- SLS $0.77
- PDEX $23.68
- 52 Week High
- SLS $2.27
- PDEX $70.26
- Technical
- Relative Strength Index (RSI)
- SLS 42.73
- PDEX 30.34
- Support Level
- SLS $1.65
- PDEX $31.72
- Resistance Level
- SLS $2.01
- PDEX $47.81
- Average True Range (ATR)
- SLS 0.11
- PDEX 2.08
- MACD
- SLS -0.02
- PDEX -1.00
- Stochastic Oscillator
- SLS 11.11
- PDEX 6.03
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.